From The Defender: FDA Slow-Walked Studies on COVID Vaccine Safety Signals in Elderly

Dr. James Lyons Weiler

“The U.S. Food and Drug Administration took more than a year to follow up on a potential increase in serious adverse events in elderly people who received Pfizer’s COVID-19 vaccine, according to an investigative report published Tuesday by The BMJ.”

Remember when I reported 21% serious adverse events in the Moderna data?

Evidently Pfizer and FDA decided they needn’t bother to report Pfizer’s data.

Read the full story on The Defender.

Comments to: From The Defender: FDA Slow-Walked Studies on COVID Vaccine Safety Signals in Elderly

Your email address will not be published. Required fields are marked *